Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • RNAarecrazy
    Junior Member
    • Jan 2014
    • 4

    #1

    MEDIP-seq: low unique reads

    Hi everyone, I mapped my medip-seq on mouse liver genome single end data with Bowtie 2 and only 10% of reads map to the mouse genome once, so only 1 million reads are "unique". Large proportion of reads either didn't map (12-17%) or mapped more than once (~75%). Here are the statistics below. My questions are:

    1) What could have caused this? Is this a biological or technical artifact?
    2) Is this data set still good?
    3) Should I only use the unique reads for downstream analyses?
    I appreciate all your help!! Thank you.

    Sample Total reads Aligned 0 times Aligned 1 time Aligned >1 times
    G109_M1 20872364 2912778 (13.96%) 1923779 (9.22%) 16035807 (76.83%)
    G109_M2 17193030 2771061 (16.12%) 1460643 (8.50%) 12961326 (75.39%)
    G109_M3 16982463 2786419 (16.41%) 1934671 (11.39%) 12261373 (72.20%)
    G109_M4 18290035 2242861 (12.26%) 1584429 (8.66%) 14462745 (79.07%)
    G109_M6 22931771 3452390 (15.06%) 2257734 (9.85%) 17221647 (75.10%)
    G109_M7 17036045 2166101 (12.71%) 1466390 (8.61%) 13403554 (78.68%)
    G109_M8 20080531 2736002 (13.63%) 1936385 (9.64%) 15408144 (76.73%)
    G109_M9 24497398 4164766 (17.00%) 2681647 (10.95%) 17650985 (72.05%)

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...